Abstract:Metal-based complexes have occupied a pioneering niche in the treatment of many chronic diseases, including various types of cancers. Despite the phenomenal success of cisplatin for the treatment of many solid malignancies, a limited number of metallo-drugs are in clinical use against cancer chemotherapy till date. While many other prominent platinum and non‑platinum- based metallo-drugs (e.g. NAMI-A, KP1019, carboplatin, oxaliplatin, titanocene dichloride, casiopeinas® etc) have entered clinical trials, many have failed at later stages of R&D due to deleterious toxic effects, intrinsic resistance and poor pharmacokinetic response and low therapeutic efficacy. Nonetheless, research in the area of medicinal inorganic chemistry has been increasing exponentially over the years, employing novel target based drug design strategies aimed at improving pharmacological outcomes and at the same time mitigating the side-effects of these drug entities. Over the last few decades, natural products became one of the key structural motifs in the anticancer drug development. Many eminent researchers in the area of medicinal chemistry are devoted to develop new 3d-transition metal-based anticancer drugs/repurpose the existing bioactive compounds derived from myriad pharmacophores such as coumarins, flavonoids, chromones, alkaloids etc. Metal complexes of natural alkaloids and their analogs such as luotonin A, jatrorrhizine, berberine, oxoaporphine, 8-oxychinoline etc. have gained prominence in the anticancer drug development process as the naturally occurring alkaloids can be anti-proliferative, induce apoptosis and exhibit inhibition of angiogenesis with better healing effect. While some of them are inhibitors of ERK signal-regulated kinases, others show activity based on cyclooxygenases-2 (COX-2) and telomerase inhibition. However, the targets of these alkaloid complexes are still unclear, though it is well-established that they demonstrate anticancer potency by interfering with multiple pathways of tumorigenesis and tumor progression both in vitro and in vivo. Over the last decade, many significant advances have been made towards the development of natural alkaloid-based metallo-drug therapeutics for intervention in cancer chemotherapy that have been summarized below and reviewed in this article.

Macromolecules incorporating transition metals in the treatment and detection of cancer and infectious diseases: Progress over the last decade

Recent Advances in Functional‐Polymer‐Decorated Transition‐Metal Nanomaterials for Bioimaging and Cancer Therapy

A review of recent advances in the use of complex metal nanostructures for biomedical applications from diagnosis to treatment

Photoresponsive metallopolymer nanoparticles for cancer theranostics

Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects

Metal-Polymer Nanoconjugates Application in Cancer Imaging and Therapy

ChemInform Abstract: Metal‐Containing and Related Polymers for Biomedical Applications

Organometallic d6, d8 and d10 metal complexes for biosensing and imaging, cancer therapy and theranosis

Advancements of metallic nanoparticles: A promising frontier in cancer treatment

Recent advances in Cu(II)/Cu(I)-MOFs based nano-platforms for developing new nano-medicines

A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: Designing, recent trends, challenges, and prospects

Biomedical Applications of Metal−Organic Frameworks for Disease Diagnosis and Drug Delivery: A Review

Recent Advances of Metal–Polyphenol Coordination Polymers for Biomedical Applications

Recent development of amorphous metal coordination polymers for cancer therapy

Amorphous Metal–organic Frameworks: Pioneering Frontiers in Cancer Diagnostics and Therapeutics

Recent Developments in Antimicrobial and Antiviral Agents Based on Natural/Synthetic Polymers and Dendrimers: Design and Therapeutic Applications

A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies

Synthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection

Anti-cancer property and DNA binding interaction of first row transition metal complexes: A decade update

Metal‐Based Nanomaterials in Biomedical Applications: Antimicrobial Activity and Cytotoxicity Aspects

Stimuli-Responsive Therapeutic Metallodrugs